Andras Miklosi

Established external business opportunities for out-licensing, co-development, spin-out, acquisition and further structured transactions focused on antibody based therapeutics. Facilitated term-sheet development, negotiations, deal closure and alliance management Contributed to the definition, revision of business development & licensing strategy, in line with corporate and portfolio strategies. Represented the company at industry, investor and partnering conferences as well as developed and maintained relationships across internal and external stakeholders and investors.

Driving innovation to capture the life science markets by developing and commercializing end-to-end workflows that seamlessly connect consumable reagent kits with data acquisition and machine learning-based analysis. Leading Development of the EV Profiler Kit and technology Developing the ONI Discovery Kit™: dSTORM in Cells. Developing ONI's LNP Profiler technology. Enhancing ONI's product portfolio by scouting, assessing technologies, reagents, and services for in-licensing, white-labeling, and integration into kits. Managing strategic partnerships, supplier reagent agreements, scientific collaborations. On site customer visits and demos to enable technology adoption and capture VoC. Representing ONI and giving presentations at conferences user group meetings and symposia. Scientific strategy manager and Principal investigator of a 1.02 million GBP NIHR i4i innovation grant awarded for the development of an SMLM and ML based diagnostics tool and broader technology adoption in clinical markets. Leading a development team of three scientists through direct and matrix management.

Applying dSTORM, light sheet microscopy in combination with optical clearing, transgenic mice and human brain biopsy samples to understand and assess neurodevelopmental and systemic pathologies induced by prenatal drug exposure.

Super-resolution dSTORM assisted pharmacological screening tool development based on the nanoscale organisation of neurotransmitter receptors in synaptosomes isolated from rat brain hippocampus.

Collaboration with the aim of electron microscopical characterization of synaptosome preparation used for dSTORM super-resolution imaging.

Investigation of novel cognitive enhancer induced changes in neurotransmitter receptor complex formation, synaptic morphology, brain region activity and memory associated behaviors.

Study of novel dopamine reuptake inhibitors as candidates for cognitive enhancement.

Examination of the molecular evolution of P-type endoplasmic reticulum Ca2+ ATPases by bioinformatic methods

Specialization in drug discovery and entrepreneurship

Specialization in biochemistry and cell biology